Eden Strategy Institute
2
537K
1
0.18
1
0.50
- Areas of investment
Summary
In 2010 was created Eden Strategy Institute, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Singapore. The fund was located in Asia if to be more exact in Singapore.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2016. The usual things for fund are deals in the range of 100 thousands - 1 million dollars.
The typical case for the fund is to invest in rounds with 1-2 participants. The meaningful sponsors for the fund in investment in the same round are SpesNet Pte. Ltd.. In the next rounds fund is usually obtained by SpesNet Pte. Ltd., Openspace Ventures, Aviva Ventures.
Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. Among the most successful fund investment fields, there are Predictive Analytics, Artificial Intelligence. Among the various public portfolio startups of the fund, we may underline Biofourmis For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.18
- Follow on index
- 0.50
- Investments by industry
- Wearables (2)
- mHealth (2)
- Personal Health (2)
- Biotechnology (2)
- Predictive Analytics (2) Show 1 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 650M
- Group Appearance index
- 0.50
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Biofourmis | 10 Aug 2016 | Biotechnology, Personal Health, Therapeutics, mHealth, Predictive Analytics, Wearables | Seed | 1M | United States, Boston, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.